Kyslík Medicinální Plynný Sol

Oxygen, the active ingredient in Kyslík Medicinální Plynný Sol, is a medical gas presented as a gas for inhalation use. It is used to increase arterial oxygen tension and improve tissue oxygenation in patients with hypoxemia, respiratory distress, carbon monoxide poisoning, and anemia.

GNH USA supplies Kyslík Medicinální Plynný Sol as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals worldwide.

Oxygen is employed in oxygen therapy to address conditions characterized by inadequate tissue oxygenation.

- Hypoxemia: restores arterial oxygen levels and supports cellular metabolism. - Respiratory distress: improves oxygen delivery to assist breathing effort. - Carbon monoxide poisoning: displaces carbon monoxide from hemoglobin and accelerates clearance. - Anemia: enhances oxygen availability despite reduced hemoglobin concentration.

Supplemental oxygen can be associated with a range of adverse reactions, which vary by duration and concentration of therapy.

Common Side Effects: - Dry nasal mucosa: irritation of nasal passages. - Cough: transient irritation of airways. - Headache: mild to moderate discomfort. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Pulmonary oxygen toxicity: inflammation and fibrosis with prolonged high concentrations. - Fire hazard: increased risk of combustion in oxygen‑rich environments. - Retinopathy of prematurity: risk in premature infants exposed to high oxygen levels.

When using medical oxygen, careful monitoring and appropriate handling are essential to ensure safety and efficacy. - Assess patient oxygenation: monitor SpO2 and arterial blood gases before and during therapy. - Adjust flow rate: titrate to target SpO2 (usually 92‑96%). - Avoid hyperoxia: limit FiO2 to the lowest effective concentration. - Use appropriate delivery device: nasal cannula, mask, or ventilator circuit as indicated. - Monitor for fire risk: keep away from open flames and flammable materials. - Store at ambient temperature: keep cylinders in a well‑ventilated, dry area, protected from heat and direct sunlight.

Oxygen may interact with other agents, influencing its efficacy or safety profile.

Major Interactions (Avoid): - Nitric oxide therapy: concurrent use can produce methemoglobinemia. - Methylene blue: may reduce oxygen delivery efficacy. - High‑concentration anesthetic gases: can potentiate respiratory depression.

Moderate Interactions (Monitor Closely): - Bronchodilators: may enhance oxygen uptake, monitor response. - Sedatives: increased risk of hypoventilation, monitor respiratory status. - Carbon monoxide exposure: supplemental oxygen may mask symptoms, monitor COHb levels.